AngioDynamics Inc (ANGO.OQ) Quote| Reuters.com
Edition:
United States

AngioDynamics Inc (ANGO.OQ)

ANGO.OQ on NASDAQ Stock Exchange Global Select Market

13.50USD
4:00pm EDT
Change (% chg)

$0.06 (+0.45%)
Prev Close
$13.44
Open
$13.36
Day's High
$13.60
Day's Low
$13.21
Volume
48,380
Avg. Vol
39,608
52-wk High
$16.98
52-wk Low
$9.71

ANGO.OQ

Chart for ANGO.OQ

About

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease, and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided... (more)

Overall

Beta: 0.85
Market Cap(Mil.): $488.77
Shares Outstanding(Mil.): 36.37
Dividend: --
Yield (%): --

Financials

  ANGO.OQ Industry Sector
P/E (TTM): -- 46.71 34.11
EPS (TTM): -0.04 -- --
ROI: -0.18 11.65 14.23
ROE: -0.24 13.64 15.46

BRIEF-Angiodynamics Q3 adjusted non-gaap earnings per share $0.15

* Q3 earnings per share view $0.14 -- Thomson Reuters I/B/E/S

Apr 07 2016

BRIEF-Angiodynamics appoints James Clemmer as new president and CEO

* Angiodynamics Appoints James C. Clemmer As New President And Chief Executive Officer

Apr 04 2016

AngioDynamics must face patent claims over injection ports

Medical device maker AngioDynamics Inc must face a patent lawsuit filed by rival CR Bard Inc over skin implants used to make injections easier, a judge has ruled.

Jan 13 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.